HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Liu Selected Research

astressin-2B

1/2022Corticotropin-Releasing Factor Aggravates Ischemic Stroke Injury by the Inflammatory Activation of Microglia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Liu Research Topics

Disease

115Neoplasms (Cancer)
02/2022 - 09/2004
62Inflammation (Inflammations)
05/2022 - 05/2003
28Vitiligo
01/2022 - 03/2009
28Hepatocellular Carcinoma (Hepatoma)
09/2021 - 09/2004
22Atherosclerosis
10/2022 - 05/2003
22Breast Neoplasms (Breast Cancer)
04/2022 - 02/2011
21Parkinson Disease (Parkinson's Disease)
11/2022 - 12/2012
18Hypoxia (Hypoxemia)
08/2022 - 01/2009
17Hypertension (High Blood Pressure)
01/2022 - 01/2011
17Wounds and Injuries (Trauma)
12/2021 - 11/2003
16Acute Lung Injury
08/2021 - 10/2008
16Coronary Disease (Coronary Heart Disease)
01/2021 - 06/2003
15Lung Injury
01/2022 - 07/2013
15Infections
01/2022 - 07/2010
15Neoplasm Metastasis (Metastasis)
01/2022 - 01/2006
15Ischemia
01/2022 - 03/2003
15Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2008
15Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 08/2005
13Ischemic Stroke
01/2022 - 08/2006
13Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 08/2011
12Asthma (Bronchial Asthma)
01/2022 - 01/2004
12Carcinogenesis
01/2022 - 01/2012
12Stroke (Strokes)
01/2022 - 06/2014
12Epilepsy (Aura)
12/2021 - 04/2008
12Carcinoma (Carcinomatosis)
09/2021 - 03/2008
12Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021 - 10/2010
11Obesity
01/2022 - 01/2013
11Sepsis (Septicemia)
01/2021 - 05/2004
11Alzheimer Disease (Alzheimer's Disease)
01/2020 - 02/2005
10Necrosis
07/2022 - 03/2003
10Body Weight (Weight, Body)
06/2022 - 07/2012
10Melanoma (Melanoma, Malignant)
04/2022 - 09/2003
10Reperfusion Injury
12/2021 - 03/2003
10Cognitive Dysfunction
11/2020 - 01/2013
9Hemorrhage
11/2022 - 01/2011
9Pain (Aches)
01/2022 - 03/2007
9Aortic Dissection
12/2020 - 11/2018
9Neuroinflammatory Diseases
12/2019 - 12/2011
9Brain Ischemia (Cerebral Ischemia)
04/2016 - 01/2009
8Myocardial Infarction
05/2022 - 11/2002
8Fibrosis (Cirrhosis)
07/2021 - 12/2013
8Septic Shock (Toxic Shock Syndrome)
01/2020 - 09/2007
8Insulin Resistance
05/2019 - 06/2008
7Seizures (Absence Seizure)
02/2022 - 12/2009
7Heart Failure
11/2021 - 09/2009
7Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 11/2014
7Neurodegenerative Diseases (Neurodegenerative Disease)
12/2019 - 09/2012
6Respiratory Insufficiency (Respiratory Failure)
10/2022 - 02/2015

Drug/Important Bio-Agent (IBA)

65Proteins (Proteins, Gene)FDA Link
11/2022 - 08/2008
35Biomarkers (Surrogate Marker)IBA
05/2022 - 03/2007
33CytokinesIBA
01/2022 - 11/2003
29Pharmaceutical PreparationsIBA
07/2022 - 05/2012
24MicroRNAs (MicroRNA)IBA
09/2021 - 04/2012
23Messenger RNA (mRNA)IBA
06/2021 - 09/2003
21LipidsIBA
10/2022 - 08/2004
19EnzymesIBA
11/2022 - 01/2009
18LipopolysaccharidesIBA
01/2022 - 01/2009
18Long Noncoding RNAIBA
01/2022 - 01/2015
17oxidized low density lipoproteinIBA
10/2022 - 03/2003
17DNA (Deoxyribonucleic Acid)IBA
03/2022 - 01/2006
13Biological ProductsIBA
07/2022 - 09/2004
13Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 03/2003
13AntioxidantsIBA
01/2021 - 10/2009
13Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2009
12Triglycerides (Triacylglycerol)IBA
10/2022 - 06/2003
12Oxygen (Dioxygen)IBA
01/2022 - 09/2007
12Therapeutic UsesIBA
01/2022 - 09/2009
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 07/2006
11Interleukin-6 (Interleukin 6)IBA
01/2022 - 11/2003
10InterleukinsIBA
01/2022 - 11/2003
10Peptides (Polypeptides)IBA
11/2021 - 06/2012
10Angiotensin IIIBA
01/2020 - 10/2008
8Apolipoproteins E (ApoE)IBA
05/2022 - 01/2013
8RNA (Ribonucleic Acid)IBA
04/2022 - 04/2012
8Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 08/2011
8C-Reactive ProteinIBA
01/2022 - 08/2003
8ChemokinesIBA
09/2021 - 12/2006
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 08/2007
8Tissue Kallikreins (Tissue Kallikrein)IBA
10/2016 - 10/2009
7Small Interfering RNA (siRNA)IBA
01/2022 - 08/2011
7Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 08/2012
7CholesterolIBA
01/2021 - 02/2011
7Phosphotransferases (Kinase)IBA
01/2021 - 01/2012
7Phenobarbital (Luminal)FDA Link
12/2020 - 01/2010
7Insulin (Novolin)FDA Link
10/2020 - 07/2012
7Neuroprotective AgentsIBA
01/2020 - 01/2009
7Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2020 - 06/2013
7Amyloid (Amyloid Fibrils)IBA
01/2019 - 12/2012
6Lipoproteins (Lipoprotein)IBA
10/2022 - 04/2010

Therapy/Procedure

68Therapeutics
09/2022 - 02/2007
16Drug Therapy (Chemotherapy)
01/2022 - 01/2014
10Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 07/2012
10Artificial Respiration (Mechanical Ventilation)
01/2022 - 01/2013
9Aftercare (After-Treatment)
02/2022 - 08/2011
9Ligation
01/2022 - 03/2003
9Transplantation
01/2022 - 09/2004
8Length of Stay
01/2022 - 08/2013
8Mechanical Ventilators (Ventilator)
01/2022 - 08/2012
7Immunotherapy
01/2022 - 11/2016
7Positive-Pressure Respiration (Positive End-Expiratory Pressure)
09/2015 - 08/2005